Navigation Links
BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
Date:5/15/2009

WOBURN, Mass., May 15 /PRNewswire/ -- BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious disease, announced today that the results from a Phase I/II combination study in previously untreated patients with head and neck cancer will be presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place May 29, 2009 - June 2, 2009 in Orlando, FL.

The results are to be presented in an abstract (number 6018) entitled, "Phase I/II dose escalation study of OncoVEX GM-CSF and chemoradiotherapy (CRT) in untreated stage III/IV squamous cell cancer of the head and neck (SCCHN)," at a poster session on Friday, May 29, 2009 from 2:00pm - 6:00pm EDT on Level 2, West Hall F3 of the conference. A poster discussion will take place from 5:00pm - 6:00pm EDT.

Study Rationale

Patients with head and neck cancer often present with bulky disease that is too large or too close to vital organs for surgical removal. These patients typically undergo radiation and chemotherapy treatment prior to surgery. Patients who present with tumor containing lymph nodes are particularly difficult to treat and approximately half of these patients relapse within two years.

In this study, OncoVEX GM-CSF was administered by direct injection, at three dose levels, into tumor containing lymph nodes in combination with standard first line chemo radiotherapy every three weeks for four cycles. All patients then went for surgery. Of the 17 Stage III/IVA (N1-3) patients treated, 16 had N2 or N3 disease.

Study Results

The abstract, now available online at www.asco.org, reports that OncoVEX GM-CSF was well tolerated, with no significant additional side effects noted over and above those which are common with chemoradiation alone.
'/>"/>

SOURCE BioVex Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
2. BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
3. BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
4. BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes
5. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
6. Spherix Reports Second Quarter Earnings
7. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
8. Tapestry Reports Second Quarter 2007 Results
9. Callisto Reports on Second-Quarter 2007 Milestones
10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... , June 3, 2015  Diomics today announced that ... senior official, has joined the company,s board of directors, ... Intelligence Studies Project and Clinical Professor at the Lyndon ... of Texas at Austin. "Steve brings ... served 28 years as a member of CIA,s clandestine ...
(Date:6/3/2015)... CORONA, Calif. , June 3, 2015  Giving ... is the ultimate mission of the International Academy ... offer treatments and resources that are at the forefront ... eye care professionals in the technology and latest treatment ... that has not been remedied with traditional means. Recently, ...
(Date:6/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/t3kkhg/the_future_of ) has ... of Pharmaceutical Outsourcing" report to their offering. ... need to develop better drugs with high success ... increasingly utilizing external resources to increase their efficiency ... internal operation. Their outsourcing demands and proportions have ...
Breaking Medicine Technology:Former CIA Clandestine Service Senior Official Stephen B. Slick joins Diomics Board of Directors 2International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 2International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 3International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 4The Future of Pharmaceutical Outsourcing: 2015 Report 2
... (NYSE: AME ) today announced that it ... of custom, fine-featured components used in the medical device ... in Montevideo, MN, has annual sales of approximately $25 ... of businesses that serve the highly attractive medical device ...
... NEW YORK, April 28, 2011 Reportlinker.com ... is available in its catalogue: ... Healthcare System and Drug Regulatory Overview: Cost-containment ... http://www.reportlinker.com/p0487111/Pharmaceutical-Key-Trends-2011---Healthcare-System-and-Drug-Regulatory-Overview-Cost-containment-and-regulatory-pressures-intensify.html ...
Cached Medicine Technology:AMETEK ACQUIRES AVICENNA TECHNOLOGY 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 3Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 4Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 5Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 6
(Date:6/3/2015)... BC (PRWEB) June 03, 2015 Vancouver ... announced that the firm will now handle personal injury ... Greater Vancouver on the rise, more and more people ... year bus accidents cause needless suffering, serious injury and ... a result of a bus accident in BC you ...
(Date:6/3/2015)... June 03, 2015 Array Health ... technology, has announced that CEO Jonathan Rickert will present ... on June 4, 2015. The session will address ... are disrupting traditional business models in health care, and ... , WHAT: Digital Transformation and the Health Care ...
(Date:6/3/2015)... 2015 A group of nine authors ... a Global Inspire Award at DIA’s upcoming Annual Meeting. ... volunteers for their leadership, level of excellence, and commitment ... The recipients of the Author(s) of the Year Award, ... article has made a significant impact in advancing medical ...
(Date:6/3/2015)... 2015 Z-Medica®, LLC, a leading developer ... has been designated as National Safety Month by the ... Police Department for its commitment to public safety. ... Individual First Aid Kits (IFAK) over 100 times in ... stabbings or traffic accidents. Each kit is equipped with ...
(Date:6/3/2015)... NC (PRWEB) June 03, 2015 Researchers ... two biomarkers for mesothelioma and say the tried-and-true marker ... just posted an article on the research. Click ... the University’s National Center for Asbestos Related Diseases say, ... positive results, it is still preferable to fibulin-3 for ...
Breaking Medicine News(10 mins):Health News:Jiwa Law Corporation Now Handles Personal Injury Claims Involving Bus Accidents 2Health News:Array Health’s CEO to Present at America’s Health Insurance Plans Institute 2015 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 4Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2Health News:Analysis Reveals Gold Standard Mesothelioma Biomarker Still the Best, According to Surviving Mesothelioma 2
... Secretary of State Colin Powell, a strong advocate for national ... the world and call upon them to continue their efforts ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081014/DC38855LOGO ) ... the importance and value of volunteerism as part of the ...
... FDA compliant solution that works within minutes to relieve the ... on stings caused by the Portuguese man-of-war. Jellyfish Squish(TM) ... can be purchased online and at select stores including drug ... of 2009 Dr. Peter Verity, a world renowned marine biologist ...
... August and September, PF Week Sept. 14 - 21 ... for Pulmonary Fibrosis (CPF) announced today it has scheduled its 2009 ... The primary goals of this year,s activity are to ensure passage ... of Congress and in communities nationwide. , , Specifically, the ...
... ... ... National HIV Testing Day, June 27, by encouraging people of all ages to learn about HIV, ... vaginal fluids or breast milk. Exposure to any of these fluids can put you at ...
... and Medicare plan participants in Ga. now have access ... , June 25 UnitedHealthcare and ... services of Fusion Sleep,s sleep disorder program available to ... , , "Fusion Sleep provides a very important ...
... French . , Montreal, June 25th 2009 ... have two choices: inject them with medication to dissolve the ... open the blocked artery (primary percutaneous coronary intervention (PCI)). Guidelines ... that do not take "real-life" conditions into account. The latest ...
Cached Medicine News:Health News:Colin Powell Applauds Lions for Leadership in Volunteerism as Interest in Volunteer Service Grows 2Health News:Popular Jellyfish Sting Treatment Also Proven Effective on Stings From Portuguese Man-of-War 2Health News:Popular Jellyfish Sting Treatment Also Proven Effective on Stings From Portuguese Man-of-War 3Health News:CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 2Health News:CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 3Health News:CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 4Health News:Planned Parenthood Recognizes National HIV Testing Day 2Health News:UnitedHealthcare and Fusion Sleep Announce New Agreement 2Health News:Research: Improving treatment of patients with heart attack 2
...
... A wide range of miniTHERM incubators is ... appropriate application solution for their specific requirements. ... liters, are compact and extremely space saving. ... microwave oven. It is possible to stack ...
... miniTHERM incubators is available, ensuring the customers ... their specific requirements. miniTHERM incubators have a ... extremely space saving. Their size corresponds approximately ... possible to stack up to three units ...
... miniTHERM incubators is available, ensuring the customers ... their specific requirements. miniTHERM incubators have a ... extremely space saving. Their size corresponds approximately ... possible to stack up to three units ...
Medicine Products: